Assessment of MDD Management in Andalusia

Completed

• Conditions: MDD Management Strategies

• Registration Number: NCT01510886
• Lead Sponsor: AstraZeneca

Brief Summary

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

Detailed Description

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Study Timeline

• Study First Submitted: 2012-01-12
• Study First Submitted QC: 2012-01-17
• Study First Posted: 2012-01-18
• Study Start: 2012-06
• Primary Completion: 2013-09
• Study Completion: 2013-09
• Status Verified: 2014-08
• Last Update Submitted: 2014-08-12
• Last Update Posted: 2014-08-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5309

Inclusion Criteria

• MDD Diagnosis Participants of the PismaEP study 18 yo. or older

Exclusion Criteria

• No specific exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of Referrals	From Jan 2010 to Jan 2011
Number of Visits to Primary Care	From Jan 2010 to Jan 2011
Number of Visits to Secondary Care	From Jan 2010 to Jan 2011

Secondary Outcome Measures

Name	Time	Method
Demographics	From Jan 2010 to Jan 2011
Type of site	From Jan 2010 to Jan 2011
Severity of disease	From Jan 2010 to Jan 2011
Type of therapeutic strategy	From Jan 2010 to Jan 2011
Type of disease	From Jan 2010 to Jan 2011

Trial Locations

Locations (1)

Research Site; 🇪🇸 Granada, Spain